OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Surrogate test performance for SARS‐CoV ‐2 neutralizing antibodies ( nAbs ) for convalescent plasma ( CCP ): How useful could they be?
Silvano Wendel, Roberta Fachini, Rita Fontão‐Wendel, et al.
Transfusion (2021) Vol. 61, Iss. 12, pp. 3455-3467
Open Access | Times Cited: 7
Silvano Wendel, Roberta Fachini, Rita Fontão‐Wendel, et al.
Transfusion (2021) Vol. 61, Iss. 12, pp. 3455-3467
Open Access | Times Cited: 7
Showing 7 citing articles:
Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time
Grace Kenny, Sophie O’Reilly, N. Kelly, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Grace Kenny, Sophie O’Reilly, N. Kelly, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, et al.
Vaccine (2022) Vol. 40, Iss. 12, pp. 1761-1767
Open Access | Times Cited: 15
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, et al.
Vaccine (2022) Vol. 40, Iss. 12, pp. 1761-1767
Open Access | Times Cited: 15
Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2
Cara O'Mahoney, Ian N. Watt, Sebastian Fiedler, et al.
Annals of Biomedical Engineering (2024) Vol. 52, Iss. 6, pp. 1653-1664
Open Access
Cara O'Mahoney, Ian N. Watt, Sebastian Fiedler, et al.
Annals of Biomedical Engineering (2024) Vol. 52, Iss. 6, pp. 1653-1664
Open Access
The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness
Cynthia So‐Osman, Thierry Burnouf, Arwa Z. Al‐Riyami, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Cynthia So‐Osman, Thierry Burnouf, Arwa Z. Al‐Riyami, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Time-related changes in the titer of virus neutralizing antibodies against SARS-CoV-2 after COVID-19 in patients with HIV infection
О. Е. Pobegalova, N. V. Kozmovskaya, N. E. Monakhov, et al.
HIV Infection and Immunosuppressive Disorders (2023) Vol. 14, Iss. 4, pp. 59-66
Open Access
О. Е. Pobegalova, N. V. Kozmovskaya, N. E. Monakhov, et al.
HIV Infection and Immunosuppressive Disorders (2023) Vol. 14, Iss. 4, pp. 59-66
Open Access
Indications and contraindications for convalescent plasma therapy in COVID-19 — a mini-review
Tomasz Wasiluk, Mariola Matulewicz, Agnieszka Żebrowska, et al.
Medical Research Journal (2022) Vol. 7, Iss. 2, pp. 176-180
Open Access
Tomasz Wasiluk, Mariola Matulewicz, Agnieszka Żebrowska, et al.
Medical Research Journal (2022) Vol. 7, Iss. 2, pp. 176-180
Open Access
